(Q35765168)

10 August 2017

1 reference

title

Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management (English)

1 reference

10 August 2017

1 reference

1 reference

Fadi El-Atat

1

1 reference

10 August 2017

Samy I McFarlane

series ordinal

2

1 reference

10 August 2017

James R Sowers

series ordinal

3

1 reference

10 August 2017

language of work or name

1 reference

1 June 2004

1 reference

Current Hypertension Reports

10 August 2017

published in

1 reference

10 August 2017

volume

6

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

215-223

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-004-0072-y

10 August 2017

exact match

0 references

cites work

Diabetes, hypertension, and cardiovascular disease: an update

1 reference

https://api.crossref.org/works/10.1007%2FS11906-004-0072-Y

Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-004-0072-Y

Hyperinsulinemia in normotensive offspring of hypertensive parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-004-0072-Y

Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-004-0072-Y

Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-004-0072-Y

Salt sensitivity and resistance of blood pressure. Age and race as factors in physiological responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-004-0072-Y

Sodium and volume sensitivity of blood pressure. Age and pressure change over time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-004-0072-Y

Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-004-0072-Y

Orthostatic hypertension. Pathogenetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-004-0072-Y

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-004-0072-Y

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-004-0072-Y

Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-004-0072-Y

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

12 December 2020

Salt sensitive human hypertension

1 reference

12 December 2020

Diabetes and cardiovascular disease.

1 reference

12 December 2020

Insulin resistance and cardiovascular disease

1 reference

12 December 2020

Microalbuminuria in diabetes: focus on cardiovascular and renal risk reduction

1 reference

12 December 2020

Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide

1 reference

12 December 2020

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

12 December 2020

The role of delayed orthostatic hypotension in the pathogenesis of chronic fatigue

1 reference

12 December 2020

Insulin resistance and blood pressure in Dahl rats and in one-kidney, one-clip hypertensive rats

1 reference

12 December 2020

Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

1 reference

12 December 2020

Treatment of hypertension in adults with diabetes

1 reference

12 December 2020

Effects of antihypertensive treatment on endpoints in the diabetic patients randomized in the Systolic Hypertension in Europe (Syst-Eur) trial.

1 reference

12 December 2020

Obesity-hypertension: the effects on cardiovascular and renal systems

1 reference

12 December 2020

Quality of life and cough on antihypertensive treatment: a randomised trial of eprosartan, enalapril and placebo

1 reference

12 December 2020

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

12 December 2020

Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease

1 reference

12 December 2020

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

1 reference

12 December 2020

Relationship between blood pressure, plasma insulin and triglyceride concentration, and insulin action in spontaneous hypertensive and Wistar-Kyoto rats

1 reference

12 December 2020

Incidence and precursors of hypertension in young adults: the Framingham Offspring Study

1 reference

12 December 2020

Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients

1 reference

12 December 2020

Insulin resistance: the shape of things to come.

1 reference

12 December 2020

Spectrum of autonomic cardiovascular neuropathy in diabetes

1 reference

12 December 2020

Interactions between insulin and sodium homeostasis in essential hypertension.

1 reference

12 December 2020

Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

1 reference

12 December 2020

[Effect of intensive antihypertensive treatment and of aspirin in a low dose in the hypertensive. The HOT (Hypertension Optimal Treatment) study]

1 reference

12 December 2020

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

12 December 2020

Therapeutic advantages of AT1 blockers in hypertension.

1 reference

12 December 2020

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

1 reference

12 December 2020

Achieving goal blood pressure in patients with type 2 diabetes: conventional versus fixed-dose combination approaches

1 reference

12 December 2020

Salt-sensitive hypertension in ANP knockout mice: potential role of abnormal plasma renin activity.

1 reference

12 December 2020

Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives.

1 reference

12 December 2020

Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers

1 reference

12 December 2020

Insulin hypersecretion: a distinctive feature between essential and secondary hypertension

1 reference

12 December 2020

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

1 reference

12 December 2020

Increased sympathetic activity during sleep and nocturnal hypertension in Type 2 diabetic patients with diabetic nephropathy.

1 reference

12 December 2020

A chronotherapeutic approach to the management of hypertension

1 reference

12 December 2020

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group

1 reference

12 December 2020

Improvements in blood pressure, glucose metabolism, and lipoprotein lipids after aerobic exercise plus weight loss in obese, hypertensive middle-aged men.

1 reference

12 December 2020

Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study

1 reference

12 December 2020

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

1 reference

12 December 2020

Vascular insulin/insulin-like growth factor-1 resistance in female obese Zucker rats

1 reference

12 December 2020

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

12 December 2020

Mechanisms of obesity-associated cardiovascular and renal disease

1 reference

12 December 2020

Cardiometabolic syndrome: pathophysiology and treatment

1 reference

12 December 2020

Microalbuminuria: is it a valid predictor of cardiovascular risk?

1 reference

12 December 2020

Obesity hypertension: role of leptin and sympathetic nervous system

1 reference

12 December 2020

Calcium antagonists in patients with type 2 diabetes and hypertension.

1 reference

12 December 2020

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

12 December 2020

Treatment of cardiovascular and renal risk factors in the diabetic hypertensive

1 reference

12 December 2020

Prevention of type 2 diabetes

1 reference

12 December 2020

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

12 December 2020

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group

1 reference

12 December 2020

Interactive effects of insulin-like growth factor-1 and β-estradiol on endothelial nitric oxide synthase activity in rat aortic endothelial cells

1 reference

12 December 2020

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group

1 reference

12 December 2020

Insulin resistance is associated with reduced nocturnal falls of blood pressure in normotensive, nonobese type 2 diabetic subjects

1 reference

12 December 2020

Antihypertensive therapy and the risk of type 2 diabetes mellitus

1 reference

12 December 2020

Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

Significance of microalbuminuria in long-duration type 1 diabetes

1 reference

12 December 2020

Microalbuminuria in patients with non-insulin-dependent diabetes mellitus relates to nocturnal systolic blood pressure

1 reference

12 December 2020

Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes

1 reference

12 December 2020

Insulin resistance in offspring of hypertensive parents

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

10.1007/S11906-004-0072-Y

Identifiers

DOI

1 reference

10 August 2017

1 reference